Intuitive Investments Group plc Investment in Micrima Limited (3253S)

TIDMIIG

RNS Number : 3253S

Intuitive Investments Group plc

16 March 2021

16 March 2021

Intuitive Investments Group plc

Investment in Micrima Limited

Intuitive Investments Group plc (AIM: IIG) ("IIG" or the "Company"), a closed-end investment company focussed on the life sciences sector, announces an investment of GBP200,000 by way of convertible loan note into Micrima Limited ("Micrima") (the "Investment"). The convertible loan note has a term of three years, with 8% interest which is non-cumulative and rolls up to be part of the final conversion amount. There are detailed conversion mechanics which differ for a trade sale or future fundraise, which include, in both cases, amongst other things, conversion of the principal amount at a 20 per cent. discount to the price per share of such sale or fundraise and a valuation cap on conversion limiting potential dilution. The investment into Micrima is part of a GBP1.9 million round which is being matched by the 'Future Fund', the UK government initiative delivered by the British Business Bank, thereby providing Micrima with GBP3.8 million of funding in aggregate.

Micrima is a commercial stage company which has developed a new imaging method, the MARIA(R) system, based on radiofrequency technology to improve early diagnosis of breast cancer. Micrima has reached a significant development milestone with initial sales of its novel breast imaging technology. Micrima is now set to set to embark on a full commercial launch with distribution already established in Germany, Austria and Switzerland through an agreement with Hologic, Inc. More information on Micrima can be found at https://micrima.com/ . Micrima, per the company's unaudited management accounts, achieved a loss after tax for the year ended 31 December 2020 of GBP2.3 million and, as at 31 December 2020, had net assets of GBP773,954.

David Evans is investing GBP100,000 as part of this investment round on the same terms as the Investment. Accordingly, David Evans did not vote as a member of the Board of IIG approving the transaction.

The Investment in is the Company's eighth investment following its IPO in mid-December 2020.

For further information, please contact:

 
 Intuitive Investments Group plc                                            www.iigplc.com 
 David Evans, Executive Chairman                                           Via Walbrook PR 
  Robert Naylor, CEO 
 
 Strand Hanson Limited - Nominated 
  Adviser                                                             [phone] 
 James Harris / James Dance / James 
  Bellman 
 
 
 Turner Pope Investments (TPI) Ltd 
  - Broker                                                            [phone] 
 Andrew Thacker / Zoe Alexander 
 
 Walbrook PR Limited - Media & Investor    [phone] or [e-mail] 
  Relations 
                                                        [phone] / +44 (0) 7980 
 Sam Allen / Paul McManus                                                          541 893 
 

About Intuitive Investments Group plc

The Company is a newly established investing company, seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board's experience and in particular that of the Chairman, David Evans, to seek to generate capital growth over the long term for shareholders.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCEAPDSFEFFEFA

(END) Dow Jones Newswires

March 16, 2021 03:00 ET (07:00 GMT)